Clinical Trials · NCT01515592
Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 24
- Start date
- Jan 2006
- Locations
- 1 site, Japan
- Primary endpoint
- Adverse events